From Our Writers

77 percent of patients affected by the vape-linked pulmonary illness were using vaporizers containing both THC and nicotine; “nearly all” of the cannabis vape products, however, were obtained from “friends, family members, illicit dealers, or off the street.”

Kentucky hemp applications are set to open in about a month; interested farmers will have until March 15, 2020, to submit applications.

GW Pharmaceuticals is partnering up with New York’s Montefiore Medical Center to study CBDV, or cannabidivarin, as a treatment for autism.

A hemp farm in Whitefield, Maine has opened its doors as a pick-your-own establishment; it’s the first farm in Maine to do so and is believed to be the second publicly accessible hemp farm in the nation.

In light of the Australian Capital Territory’s recent legalization reforms, the country’s Health Minister confirmed that federal officials have “no plans” to fight the new legislation.

Maryland’s latest medical cannabis licensing round has been delayed due to an allegedly flawed application process that blocked many applicants from submitting all of the necessary materials on time.

Pennsylvania Gov. Tom Wolf has formally announced his support for adult-use cannabis legalization and called for lawmakers to craft legislation to end cannabis prohibition in the state.

The latest round of medical cannabis reforms in Massachusetts has done away with the $50 annual patient registration fee.

A CBD shop in Chicago is suing its landlord after being told they couldn’t display their logo, which contains a hemp leaf, on local signage because the landlords claim it would promote “marijuana usage.”

The House of Representatives passed the SAFE Banking Act this afternoon in a historic and bipartisan landslide of support for giving state-legal cannabis companies access to banking services.

Massachusetts regulators voted 4-1 in favor of home delivery and social consumption rules; licenses for the two new business types will be made available first to social equity and economic empowerment applicants.

Lawmakers in the Australian Capital Territory have passed legislation legalizing adult-use cannabis and home cultivation; the new rules do not, however, approve any form of cannabis distribution, including sales and gifts.

Uncle Ike’s dispensary in Seattle, Washington recently ran a barrage of lab tests on cannabis vaporizers in the shop to search for vitamin E acetate, the compound linked to a recent swell of vape-related hospitalizations. 100% of the products passed the tests.

A governor-issued ban in Massachusetts will block the sale of cannabis and nicotine vaporizer products for four months; the ban comes after 61 people in the state have fallen ill with the vape-related pulmonary illness.

The products are Ground Flower Pods from Curaleaf, they are meant for use with a vaporizer, and it’s the first cannabis flower product to be available under New York’s medical cannabis program.

New Hampshire lawmakers have blocked a governor veto against medical cannabis expansions in the state; the veto would have cemented the state’s three-month waiting period before approved cannabis patients could access their medicine.

The European Union has approved Epidiolex for the treatment of two childhood epilepsy conditions. It’s the first time the EU has approved a cannabis-based medication.

Nine universities are receiving federal grants totaling $3 million to study the “potential pain-relieving properties” of minor cannabinoids and cannabis-sourced terpenes.

New Mexico Hemp Services has secured a $250,000 state grant to provide job training for hemp industry workers in the state.

Because of Massachusetts’ host community rules and a general lack of funds, social equity applicants in the state are unable to compete fairly with larger, better-funded cannabis firms, according to Cannabis Control Commission Chairman Steven Hoffman.

Almost half of Ontario, Canada’s 42 cannabis license applicants in the second round of the licensing lottery have been disqualified for breaking rules and for failing to submit all of the required documents.

The SAFE Banking Act, which would normalize banking for the cannabis industry, is expected to receive a House vote next week.

Unregulated companies in California continue to dominate the majority of cannabis sales in the state, where illegal operators outnumber licensed companies 3-to-1.

A new Nielsen report suggests legal U.S. cannabis sales could surpass $40 billion by 2025; the sector was worth just $8 billion in 2018.